Genetix Biotherapeutics
Return to all Congress Materials

International Society for Cell & Gene Therapy (ISCT)

2018 Scientific Meeting

Materials

1

Products

Zynteglo

Featured Posters & Presentations

Oral PresentationZynteglo

Clinical outcomes following LentiGlobin gene therapy for transfusion-dependent β-thalassemia in the Northstar HGB-204 Study.

Authors: Rasko JE.